The Defense Health Agency (DHA) and the Veterans Health Administration (VHA) hold considerable potential for collaborating on various cross-cutting innovations. This presentation delves into opportunities for joint investment and innovation aimed at addressing mutual clinical and administrative challenges, improving continuity of care, and promoting the adoption of innovative practices both upstream and downstream. Emphasizing the critical need for collaboration between DHA and VHA, the presentation highlights the numerous advantages of shared investments, smoother care transitions, and the reciprocal adoption of innovative approaches. Through capitalizing on each other's strengths and insights, DHA and VHA can collectively propel healthcare delivery forward for veterans, service members, and their families.
2. Explain how innovations in predictive analytics, such as leveraging AI to identify "high-risk" service members for care gaps during transition to VA care, can enhance continuity of care between DHA and VHA.
3. Assess the importance of aligning DHA's innovation investments with VHA's initiatives to introduce service members and clinicians to new care models and technologies, fostering early buy-in and adoption within DHA.
4. Evaluate the potential for downstream innovation within DHA by replicating and scaling successful models from VHA, such as collaboration with programs like the MIT Catalyst Program, to empower frontline innovators and integrate innovative solutions effectively.